𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C

✍ Scribed by Hauser, P; Khosla, J; Aurora, H; Laurin, J; Kling, M A; Hill, J; Gulati, M; Thornton, A J; Schultz, R L; Valentine, A D

Book ID
110059459
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
99 KB
Volume
7
Category
Article
ISSN
1359-4184

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effectiveness and tolerability of paroxe
Effectiveness and tolerability of paroxetine controlled release (CR) in the treatment of major depressive disorder: an open-label, prospective, multi-center trial in Korea
✍ Chi-Un Pae; Won-Myong Bahk; Duk-In Jon; Sang-Yeol Lee; Bo-Hyun Yoon; Kyung Joon πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 127 KB πŸ‘ 2 views

## Abstract ## Objectives This study evaluated the effectiveness and tolerability of paroxetine controlled release (CR) for the treatment of Korean patients with major depressive disorder (MDD) in a naturalistic treatment setting. ## Methods One hundred and ninety patients with MDD were enrolled

The efficacy of reboxetine in the treatm
The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study
✍ P. N. Dannon; I. Iancu; L. Grunhaus πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 57 KB πŸ‘ 2 views

## Abstract ## Background and Objective Selective serotonin reuptake inhibitors (SSRIs) are currently the first‐line treatment for panic disorder, although up to 30% of patients either do not respond to SSRIs or withdraw due to adverse events. Reboxetine, a selective norepinephrine reuptake inhibi